Hydromorphone

Dilaudid, Dilaudid-hp, Exalgo, Hydromorphone, Palladone (hydromorphone) is a small molecule pharmaceutical. Hydromorphone was first approved as Dilaudid on 1984-01-11. It is used to treat cough and postoperative pain in the USA. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target delta-type opioid receptor and kappa-type opioid receptor. Hydromorphone hydrochloride's patent is valid until 2034-03-12 (FDA).